DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A•••••••••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $6.4M
sum of BDC pieces, a lower bound
Fair value
$6.0M
94c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
4
2 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Jun 20, 2028
$119,820 inside 24 months
On the tape since
Dec 31, 2021
latest Jun 30, 2026
Events
9
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $6.4M | 94c | SOFR+550 bp | Sep 20, 2028 | 2 |
| other lien unstated exited Dec 31, 2023 | at least $9.8M | 78c | S+400 bp | Jun 22, 2026 | 2 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 4.00% I••••••• R••• 7.73% A••••••••• D• | $475,313 | $446,982 94c | SOFR+400 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% A••••••••• D• | $119,820 | $113,829 98c | SOFR+550 bp |
| P••••• S••••• C•••••• B•• I••• | term loan first lien Investment F•••• L••• S••••• S•••••• L••• I••••••• R••• 7.65% (S + 4.00%) M••••••• D••• 9/ | $5.8M | $5.4M 94c | SOFR+400 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $6.4M | $6.0M | 94c | 0 |
| Mar 31, 2026 | 2 | $6.4M | $5.6M | 88c | 0 |
| Dec 31, 2025 | 2 | $12.2M | $10.3M | 84c | 0 |
| Sep 30, 2025 | 2 | $6.4M | $4.8M | 76c | 0 |
| Jun 30, 2025 | 2 | $6.4M | $5.6M | 88c | 0 |
| Mar 31, 2025 | 2 | $6.4M | $5.7M | 88c | 0 |
| Dec 31, 2024 | 2 | $7.1M | $6.5M | 93c | 0 |
| Sep 30, 2024 | 2 | $6.5M | $6.0M | 92c | 0 |
| Jun 30, 2024 | 1 | $604,883 | $585,224 | 97c | 0 |
| Mar 31, 2024 | 1 | $606,101 | $568,502 | 94c | 0 |
| Dec 31, 2023 | 3 | $16.7M | $13.2M | 79c | 0 |
| Sep 30, 2023 | 2 | $40.5M | $34.7M | 86c | 0 |
| Jun 30, 2023 | 2 | $40.5M | $33.5M | 84c | 0 |
| Mar 31, 2023 | 1 | $40.1M | $32.0M | 81c | 0 |
| Dec 31, 2022 | 2 | $80.7M | $63.8M | 80c | 0 |
| Dec 31, 2021 | 1 | $40.2M | $40.1M | 101c | 0 |
What changed
- Mark recoveredJun 30, 2026
- Mark recoveredDec 31, 2025
- Marked down across lendersSep 30, 2025
- Marked down (one lender)Sep 30, 2025
- Marked down (one lender)Mar 31, 2025
- Spread changed (observed)Sep 30, 2024
- Maturity extended (observed)Sep 30, 2024
- Spread changed (observed)Jun 30, 2024
- Mark recoveredMar 31, 2024
- Maturity extended (observed)Mar 31, 2024
- Spread increasedMar 31, 2024
- Maturity extended (observed)Mar 31, 2024
- Facility left every BDC scheduleDec 31, 2023
- New lender joined a facilityDec 31, 2023
- Lender left a facilityDec 31, 2023
- New borrower on a BDC scheduleDec 31, 2021
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- ACCENTCAREderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 4 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it